Patrick Durez

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Rheumatoid Arthritis

Top Venues

Annals of the rheumatic diseases

Rheumatology and therapy

European journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Roy M Fleischmann, Jerzy Swierkot, Sara K Penn, Patrick Durez, Louis Bessette, Xianwei Bu, Nasser Khan, Yihan Li, Charles G Peterfy, Yoshiya Tanaka, Eduardo Mysler
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study. RMD open 10 (2) (2024)
Roy M Fleischmann, Jerzy Swierkot, Sara K Penn, Patrick Durez, Louis Bessette, Xianwei Bu, Nasser Khan, Yihan Li, Charles G Peterfy, Yoshiya Tanaka, Eduardo Mysler
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study. RMD open 10 (2) (2024)
Roy M Fleischmann, Jerzy Swierkot, Sara K Penn, Patrick Durez, Louis Bessette, Xianwei Bu, Nasser Khan, Yihan Li, Charles G Peterfy, Yoshiya Tanaka, Eduardo Mysler
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study. RMD open 10 (2) (2024)
Roy M Fleischmann, Jerzy Swierkot, Sara K Penn, Patrick Durez, Louis Bessette, Xianwei Bu, Nasser Khan, Yihan Li, Charles G Peterfy, Yoshiya Tanaka, Eduardo Mysler
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study. RMD open 10 (2) (2024)
Bayram Farisoğulları, Saskia Lawson-Tovey, Kimmie L Hyrich, Laure Gossec, Loreto Carmona, Anja Strangfeld, Elsa F Mateus, Martin Schaefer, Ana Rodrigues, Eric Hachulla, José A Gómez-Puerta, Marta Mosca, Patrick Durez, Ludovic Trefond, Tiphaine Goulenok, Martina Cornalba, Emoke Stenova, Inita Bulina, Eva Strakova, Julija Zepa, Nicolas Roux, Olivier Brocq, Eric Veillard, Gerd-Rüdiger R Burmester, Xavier Mariette, Pedro M Machado, null null
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry. Annals of the rheumatic diseases (2024)
Emilie Sapart, Tatiana Sokolova, Stéphanie de Montjoye, Stéphanie Dierckx, Adrien Nzeusseu, Aleksandra Avramovska, Laurent Meric de Bellefon, Patrick Durez
Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort. Rheumatology and therapy (2023)
Clément Triaille, Gaëlle Tilman, Tatiana Sokolova, Axelle Loriot, Joelle Marchandise, Stéphanie De Montjoye, Adrien Nzeusseu Toukap, Laurent Méric de Bellefon, Caroline Bouzin, Christine Galant, Patrick Durez, Bernard R Lauwerys, Nisha Limaye
Disease activity drives transcriptomic heterogeneity in early untreated rheumatoid synovitis. Annals of the rheumatic diseases (2023)
Patrick Durez, Bernard G Combe
Should we stop methotrexate or not for vaccination? RMD open 9 (2) (2023)
Thomas Paul-Emile Kirchgesner, Maria Simona Stoenoiu, Patrick Durez, Nicolas Michoux, Bruno Vande Berg
MRI of Hands with Early Rheumatoid Arthritis: Usefulness of Three-Point Dixon Sequences to Quantitatively Assess Disease Activity. Journal of the Belgian Society of Radiology 106 (1) (2022)
Patrick Durez, Rene Westhovens, Femke Baeke, Yedid Elbez, Sofie Robert, Harris A Ahmad
Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study. BMC rheumatology 6 (1) (2022)
Roy M Fleischmann, Eduardo Mysler, Louis Bessette, Charles G Peterfy, Patrick Durez, Yoshiya Tanaka, Jerzy Swierkot, Nasser Khan, Xianwei Bu, Yihan Li, In-Ho Song
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study. RMD open 8 (1) (2022)
Aurélie Najm, Félicie Costantino, Stefano Alivernini, Alessia Alunno, Elettra Bianchi, Jacqueline Bignall, Brendan Boyce, Juan D Cañete, Francesco Carubbi, Patrick Durez, João Eurico Fonseca, Søren Andreas Just, Raquel Largo, Antonio Manzo, Mark Maybury, Esperanza Naredo, Carl Orr, Costantino Pitzalis, Felice Rivellese, Vasco C Romão, Jef van Rompay, Sander W Tas, Douglas James Veale, Maria Antonietta D'Agostino, Andrew Filer
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology. Annals of the rheumatic diseases 81 (12) (2022)
Xavier Theunssens, Laura Bricman, Stéphanie Dierckx, Emilie Sapart, Tatiana Sokolova, Aleksandra Avramovska, Patrick Durez
Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort. Rheumatology and therapy 9 (2) (2022)
Enrico Fusaro, Patrick Durez, Johannes Wohlrab, Soohyun Lee, Sangwook Yoon, Hubert Marotte
An update on the adalimumab biosimilar landscape following the approval of the first high-concentration biosimilar. Immunotherapy (2021)
Anne Grete Semb, Silvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, Joseph Sexton, Cindy Crowson, Piet van Riel, George Kitas, Ian Graham, Solbritt Rantapää-Dahlqvist, George Athanasios Karpouzas, Elena Myasoedova, Miguel Angel González-Gay, Petros P Sfikakis, Maria G G Tektonidou, Argyro Lazarini, Dimitrios Vassilopoulos, Bindee Kuriya, Carol Hitchon, Maria Simona Stoenoiu, Patrick Durez, Virginia Pascual-Ramos, Dionicio Ángel Galarza-Delgado, Pompilio Faggiano, Durga Prasanna Misra, Andrew A Borg, Rong Mu, Erkin M Mirrakhimov, Diane Gheta, Karen Douglas, Vikas Agarwal, Svetlana Myasoedova, Lev Krougly, Tatiana V Popkova, Alena Tuchyňová, Michal Tomcik, Michal Vrablik, Jiri Lastuvka, Pavel Horak, Helena Kaspar Medkova, Anne M Kerola, null null
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit. RMD open 7 (2) (2021)
Pedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, Elsa F Mateus, Kimmie L Hyrich, Laure Gossec, Loreto Carmona, Ana Rodrigues, Nicolas Roux, Catia Duarte, Eric Hachulla, Eric Veillard, Eva Strakova, Gerd-Rüdiger R Burmester, Gözde Kübra Yardımcı, José A Gómez-Puerta, Julija Zepa, Lianne Kearsley-Fleet, Ludovic Trefond, Maria Cunha, Marta Mosca, Martina Cornalba, Martin Soubrier, Nicolas Roux, Olivier Brocq, Patrick Durez, Richard P Conway, Tiphaine Goulenok, Johannes W J Bijlsma, Iain B McInnes, Xavier Mariette
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Annals of the rheumatic diseases 81 (5) (2021)
Tore K Kvien, Alejandro Balsa, Neil Betteridge, Maya H Buch, Patrick Durez, Ennio Giulio Favalli, Guillaume Favier, Cem Gabay, Rinie Geenen, Ioanna Gouni-Berthold, Frank van den Hoogen, Alison Kent, Lars Klareskog, Mikkel Ostergaard, Karel Pavelka, Joaquim Polido Pereira, Anne Grete Semb, Magnus Sköld, Maxime Dougados
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities. RMD open 6 (2) (2021)
Mark C Genovese, Patrick Durez, Roy M Fleischmann, Yoshiya Tanaka, Daniel E Furst, Hisashi Yamanaka, Elena Korneva, Igor Vasyutin, Tsutomu Takeuchi
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies. European journal of rheumatology (2021)
Céline LA, Phu Quoc Lê, Alina Ferster, Laurence Goffin, Delphine Spruyt, Bernard Lauwerys, Patrick Durez, Cecile Boulanger, Tatiana Sokolova, Joanne Rasschaert, Valérie Badot
Serum calprotectin (S100A8/A9): a promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis. RMD open 7 (2) (2021)
Charlotte Anne Baert, Selda Aydin, Philippe Leroy, Patrick Durez
Onset of IgA nephropathy in a patient treated with infliximab for ankylosing spondylitis. BMJ case reports 14 (1) (2021)
Patrick Durez, Karel Pavelka, Maria Alicia Lazaro, Abraham Garcia-Kutzbach, Robert J Moots, Howard Amital, Marinella Govoni, Nathan Vastesaeger
Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. Clinical rheumatology 37 (5) (2018)